385 related articles for article (PubMed ID: 32074617)
1. Differential Diagnosis in Patients with Substance Use Disorder and/or Attention-Deficit/Hyperactivity Disorder Using Continuous Performance Test.
Slobodin O; Blankers M; Kapitány-Fövény M; Kaye S; Berger I; Johnson B; Demetrovics Z; van den Brink W; van de Glind G
Eur Addict Res; 2020; 26(3):151-162. PubMed ID: 32074617
[TBL] [Abstract][Full Text] [Related]
2. The Utility of the CPT in the Diagnosis of ADHD in Individuals with Substance Abuse: A Systematic Review.
Slobodin O
Eur Addict Res; 2020; 26(4-5):283-294. PubMed ID: 32535592
[TBL] [Abstract][Full Text] [Related]
3. [International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder].
Özgen H; Spijkerman R; Noack M; Holtmann M; Schellekens ASA; van de Glind G; Banaschewski T; Barta C; Begeman A; Casas M; Crunelle CL; Daigre Blanco C; Dalsgaard S; Demetrovics Z; den Boer J; Dom G; Eapen V; Faraone SV; Franck J; González RA; Grau-López L; Groenman AP; Hemphälä M; Icick R; Johnson B; Kaess M; Kapitány-Fövény M; Kasinathan JG; Kaye SS; Kiefer F; Konstenius M; Levin FR; Luderer M; Martinotti G; Matthys FIA; Meszaros G; Moggi F; Munasur-Naidoo AP; Post M; Rabinovitz S; Ramos-Quiroga JA; Sala R; Shafi A; Slobodin O; Staal WG; Thomasius R; Truter I; van Kernebeek MW; Velez-Pastrana MC; Vollstädt-Klein S; Vorspan F; Young JT; Yule A; van den Brink W; Hendriks V
Z Kinder Jugendpsychiatr Psychother; 2021 Jan; 50(1):54-67. PubMed ID: 34397296
[TBL] [Abstract][Full Text] [Related]
4. Attention Deficit Hyperactivity Disorder in Prisoners: Increased Substance Use Disorder Severity and Psychiatric Comorbidity.
Vélez-Pastrana MC; González RA; Ramos-Fernández A; Ramírez Padilla RR; Levin FR; Albizu García C
Eur Addict Res; 2020; 26(4-5):179-190. PubMed ID: 32615575
[TBL] [Abstract][Full Text] [Related]
5. Attention-Deficit/Hyperactivity Disorder Symptoms, Sensation-Seeking, and Sensory Modulation Dysfunction in Substance Use Disorder: A Cross Sectional Two-Group Comparative Study.
Assayag N; Berger I; Parush S; Mell H; Bar-Shalita T
Int J Environ Res Public Health; 2022 Feb; 19(5):. PubMed ID: 35270233
[TBL] [Abstract][Full Text] [Related]
6. Naturalistic exploratory study of the associations of substance use on ADHD outcomes and function.
MacDonald B; Sadek J
BMC Psychiatry; 2021 May; 21(1):251. PubMed ID: 33980212
[TBL] [Abstract][Full Text] [Related]
7. Usefulness and Validity of Continuous Performance Tests in the Diagnosis of Attention-Deficit Hyperactivity Disorder Children.
Berger I; Slobodin O; Cassuto H
Arch Clin Neuropsychol; 2017 Feb; 32(1):81-93. PubMed ID: 28122767
[TBL] [Abstract][Full Text] [Related]
8. Attention Deficit/Hyperactivity Disorder and Global Severity Profiles in Treatment-Seeking Patients with Substance Use Disorders.
Icick R; Moggi F; Slobodin O; Dom G; Mathys F; van den Brink W; Levin FR; Blankers M; Kaye S; Demetrovics Z; van de Glind G; Velez-Pastrana MC; Schellekens ASA;
Eur Addict Res; 2020; 26(4-5):201-210. PubMed ID: 32570249
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of adults with attention deficit hyperactivity disorder plus substance use disorder: the role of psychiatric comorbidity.
Wilens TE; Kwon A; Tanguay S; Chase R; Moore H; Faraone SV; Biederman J
Am J Addict; 2005; 14(4):319-27. PubMed ID: 16188712
[TBL] [Abstract][Full Text] [Related]
10. Effects of Substance Misuse and Family History of Substance Use Disorder on Delay Discounting in Adolescents and Young Adults with Attention-Deficit/Hyperactivity Disorder.
Paraskevopoulou M; van Rooij D; Schene AH; Scheres APJ; Buitelaar JK; Schellekens AFA
Eur Addict Res; 2020; 26(4-5):295-305. PubMed ID: 32659779
[TBL] [Abstract][Full Text] [Related]
11. Attention Deficit Hyperactivity Disorder Increases Nicotine Addiction Severity in Adults Seeking Treatment for Substance Use Disorders: The Role of Personality Disorders.
Sánchez-García NC; González RA; Ramos-Quiroga JA; van den Brink W; Luderer M; Blankers M; Grau-Lopez L; Levin FR; Kaye S; Demetrovics Z; van de Glind G; Schellekens A; Vélez-Pastrana MC;
Eur Addict Res; 2020; 26(4-5):191-200. PubMed ID: 32564016
[TBL] [Abstract][Full Text] [Related]
12. International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder.
Özgen H; Spijkerman R; Noack M; Holtmann M; Schellekens ASA; van de Glind G; Banaschewski T; Barta C; Begeman A; Casas M; Crunelle CL; Daigre Blanco C; Dalsgaard S; Demetrovics Z; den Boer J; Dom G; Eapen V; Faraone SV; Franck J; González RA; Grau-López L; Groenman AP; Hemphälä M; Icick R; Johnson B; Kaess M; Kapitány-Fövény M; Kasinathan JG; Kaye SS; Kiefer F; Konstenius M; Levin FR; Luderer M; Martinotti G; Matthys FIA; Meszaros G; Moggi F; Munasur-Naidoo AP; Post M; Rabinovitz S; Ramos-Quiroga JA; Sala R; Shafi A; Slobodin O; Staal WG; Thomasius R; Truter I; van Kernebeek MW; Velez-Pastrana MC; Vollstädt-Klein S; Vorspan F; Young JT; Yule A; van den Brink W; Hendriks V
Eur Addict Res; 2020; 26(4-5):223-232. PubMed ID: 32634814
[TBL] [Abstract][Full Text] [Related]
13. The International Collaboration on ADHD and Substance Abuse (ICASA): Mission, Results, and Future Activities.
Van de Glind G; Brynte C; Skutle A; Kaye S; Konstenius M; Levin F; Mathys F; Demetrovics Z; Moggi F; Ramos-Quiroga JA; Schellekens A; Crunelle C; Dom G; van den Brink W; Franck J
Eur Addict Res; 2020; 26(4-5):173-178. PubMed ID: 32599579
[TBL] [Abstract][Full Text] [Related]
14. Attention deficit/hyperactivity disorders with co-existing substance use disorder is characterized by early antisocial behaviour and poor cognitive skills.
Bihlar Muld B; Jokinen J; Bölte S; Hirvikoski T
BMC Psychiatry; 2013 Dec; 13():336. PubMed ID: 24330331
[TBL] [Abstract][Full Text] [Related]
15. [Recommendations for the screening, diagnosis and treatment of patients with comorbid attention deficit hyperactivity- and substance use disorder].
Kapitány-Fövény M; Barta C; Crunelle CL; van den Brink W; Moggi F; Konstenius M; Franck J; Levin FR; van de Glind G; Coetzee C; Luderer M; Schellekens A; Matthys F; Demetrovics Z;
Psychiatr Hung; 2020; 35(4):435-447. PubMed ID: 33263293
[TBL] [Abstract][Full Text] [Related]
16. Diagnosing ADHD in adults with substance use disorder: DSM-IV criteria and differential diagnosis.
Levin FR; Upadhyaya HP
J Clin Psychiatry; 2007 Jul; 68(7):e18. PubMed ID: 17685729
[TBL] [Abstract][Full Text] [Related]
17. International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder.
Crunelle CL; van den Brink W; Moggi F; Konstenius M; Franck J; Levin FR; van de Glind G; Demetrovics Z; Coetzee C; Luderer M; Schellekens A; ; Matthys F
Eur Addict Res; 2018; 24(1):43-51. PubMed ID: 29510390
[TBL] [Abstract][Full Text] [Related]
18. Impact of substance use disorder on ADHD and its treatment.
Wilens TE; Upadhyaya HP
J Clin Psychiatry; 2007 Aug; 68(8):e20. PubMed ID: 17876905
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic accuracy of attention-deficit/hyperactivity disorder in adults with substance use disorders.
Fatseas M; Debrabant R; Auriacombe M
Curr Opin Psychiatry; 2012 May; 25(3):219-25. PubMed ID: 22449768
[TBL] [Abstract][Full Text] [Related]
20. Everyday life consequences of substance use in adult patients with a substance use disorder (SUD) and co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD): a patient's perspective.
Kronenberg LM; Slager-Visscher K; Goossens PJ; van den Brink W; van Achterberg T
BMC Psychiatry; 2014 Sep; 14():264. PubMed ID: 25234344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
